Journal List > Perinatology > v.30(1) > 1127210

Park, Park, and Choi: Neonatal Severe Anemia Due to Massive Fetomaternal Hemorrhage

Abstract

Fetomaternal hemorrhage refers to the entry of fetal blood into the maternal circulation before or during delivery. Very small amount of fetal red cells are normally detectable in all pregnancies. Massive fetomaternal bleeding is very rare and even rarer is the resultant severe anemia causing early neonatal death. Especially, the bleeding occurs more than 150 mL from the fetus to the mother, defined as a massive bleeding, even though it is very rare, is known to account for more than 10% of unexplainable deaths of fetuses. Fetal blood is likely to enter the maternal circulation during all pregnancies, without apparent clinical significance in most cases. Decreased or absence of fetal movement is the most common antenatal presentation, observed in approximately 25% of all cases. We hereby report that a severe anemia and dyspnea from a newborn baby was found and that it was treated instantly right after the birth. It was a case of the massive fetomaternal hemorrhage of more than 300 mL.

References

1. Thomas A, Mathew M, Moral E, Vaclavinkova V. Acute massive fetomaternal hemorrhage. Acta Obstet Gynecolscand. 2003; 82:479–80.
2. Giacoia GP. Severe fetomaternal hemorrhage: a review. Obstet Gynecol Surv. 1997; 52:372–80.
3. Kaneda T, Shiraki K, Hirano K, Nagata I. Detection of maternofetal transfusion by placental alkaline phosphatase levels. J Pediatr. 1997; 130:7305.
crossref
4. Rubod C, Deruelle P, Le Goueff F, Tunez V, Fournier M, Subtil D. Long-term prognosis for infants after massive fetomaternal hemorrhage. Obstet Gynecol. 2007; 110(2 Pt 1):256–60.
crossref
5. Samadi R, Greenspoon JS, Gviazda I, Settlage RH, Goodwin TM. Massive fetomaternal hemorrhage and fetal death: are they predictable? J Perinatol. 1999; 19:227–9.
6. Sebring ES, Polesky HF. Fetomaternal hemorrhage: incidence, risk factor, time of occurrence, and clinical effects. Transfusion. 1990; 30:344–57.
7. Hartung J, Chaoui R, Bollmann R. Nonimmune hydrops from fetomaternal hemorrhage treated with serial fetal intravascular transfusion. Obstet Gynecol. 2000; 96(5 Pt 2):844.
crossref
8. Kleihauer E, Braun H, Betke K. Demonstration of fetal hemoglobinin erythrocytes of a blood smear. Klin Wochenschr. 1957; 35:637–8.
9. Ou CN. Diagnosis of hemoglobinopathies by high-performance liquid chromatography. J Biomed Sci. 1997; 4:315–8.
crossref
10. Tsuda H, Matsumotoa M, Sutoh Y, Hidaka A, Imanakab M, Miyazaki A. Massive fetomaternal hemorrhage. Int J Gynaecol Obstet. 1995; 50:47–9.
crossref
11. Lee JY, Kim KH, Kong SG. Massive fetomaternal hemorrhage diagnosed with high-performance liquid chromatography. Clin Pediatr Hematol Oncol. 2016; 23:158–61.
crossref
12. Boyce LH, Khandji AG, DeKlerk AM, Nordli DR. Fetomaternal hemorrhage as an etiology of neonatal stroke. Pediatr Neurol. 1994; 11:255–7.
crossref
13. Mari G, Deter RL, Carpenter RL, Rahman F, Zimmerman R, Moise KJ Jr, et al. Noninvasive diagnosis by Doppler ultrasonography of fetalanemia due to maternal red-cell alloimmunization. Collaborative Group for Doppler Assessment of the Blood Velocity in Anemic Fetuses. N Engl J Med. 2000; 342:9–14.
14. Singh P, Swanson T. Acute and chronic fetal anemia as a result of fetomaternal hemorrhage. Case Rep Obstet Gynecol. 2014; 2014:296463.
crossref
15. Kim HK, Choi MY, Yoon HS, Yun BY, Bae SW, Son DW. Clinical study on massive fetomaternal hemorrhage. Korean J Perinatol. 2001; 12:267–73.
16. Lee CH, Kim JK, Han MK, Kim JW, Lee JJ. Two cases of massive fetomaternal hemorrhage treated by exchange transfusion. Korean J Perinatol. 2008; 19:203–8.
17. Marciano A, Di Luca L, Maranella E, Conte E, Di Natale C, Pannone V, et al. How to manage fetomaternal hemorrhage? Description of five cases and literature review. J Pediatr Neonat Individual Med. 2017; 7:e070101.
18. Akanli LF, Cohen-Addad NE, Malabanan NV, Margono F, Krilov MA. Massive fetomaternal hemorrhage. Am J perinatol. 1997; 14:271–3.
crossref

Fig. 1.
The baby shows pale skin color on whole body at birth.
pn-30-40f1.tif
Fig. 2.
The infantogram shows normal cardiac size and shape, also shows intubation tube, umbilical artery and vein catheter inserted state.
pn-30-40f2.tif
Fig. 3.
The amplitude integrates electroencephalography shows continuous low voltage pattern (lower margin is continuously and without much variability at or below 5 µV and upper margin does not exceed 10 µV) and mimic seizure activity (artifact) due to handling (arrows).
pn-30-40f3.tif
Table 1.
Clinical Characteristics of Mothers with Massive Fetomaternal Hemorrhage
Case Age (years) Parity Type of delivery Risk factor∗ Hemoglobulin (g/d dL) pre/post delivery Fetal distress
Kim et al.15              
1 27 0–0–0–0 Twin C/S 11.1 10.9 DFBM, LD
2 31 0–0–1–0 C/S 11.0 10.3 LD
3 29 0–0–0–0 C/S 11.7 10.6
4 30 0–0–0–0 C/S 10.4 DFBM, LD
5 30 0–0–0–0 NFSD 11 8.9 LD
Lee et al.16              
6 ? ? NFSD 5.1 ?
7 31 0–0–1–0 C/S 3.1 ?
Marciano et al. .17            
8 30 0–0–0–0 C/S 2.8 LD
9 ? ? C/S   7.5 LD
10 ? 0–0–0–0 C/S 3.8
11 35 0–0–0–0 NFSD 9.3
12 28 2–0–1–2 C/S 8.5

Abbreviations: C/S, ceasarian section; DFBM, decreased fetal body movement; LD, late deceleration; NFSD, normal fullterm spontaneous delivery. ∗Antepatum death, abdominal trauma, placental malformation (choriocarcinoma, chorioangioma), amniocentesis, placenta previa, abruptio placenta.

Table 2.
Clinical Characteristics of Neonates with Massive Fetomaternal Hemorrhage
Case∗/sex Gestationa age (weeks l Weight s) (g) ( Apgar score 1, 5 minutes) Clinical manifestation Hb (g/dL) K-B test (%) Associated diseases Transfusio (15 mL/kg n Prognosis g)
Kim et al.15                  
1/M 33 1,880 1,1 Pale, RD, HS 4.2 20 RDS 6 Normal
1'/M 33 1,790 1,1 Pale, RD, HS 3.7 20 RDS 6 Normal
2/F 39 3,160 5,9 Pale, HS 4.4 15 Pure red cell anemia 2 Pure red cell anemia
3/M 41 3,220 6,9 Pale, HS 4.7 13 2 Normal
4/F 35 2,460 4,7 Pale, HS 5.5 8 RDS 4 Normal
5/F 41 3,250 7,10 Pale 8.8 9.2 2 Normal
Lee et al.16                  
6/F 40 3,600 ? Pale, RD, HS 5.1 6.1 (HPLC) M Metabolic acidosis, Pneumothorax 2 Normal
7/F 36 2,870 6,7 Pale, RD, HS 3.1 6.5 (HPLC) Metabolic acidosis 2 Normal
Marciano et a al.17                
8/F 39 3,225 7,8 Pale, RD, HS 2.8 ? Metabolic acidosis,    
Hypoglycem ia 2 Normal              
9/F 37 2,080 7,8 Pale, RD 7.5 ? Respiratory acidosis 2 Normal
10/M 39 3,320 8,9 Pale, RD, HS 3.8 ? PPHN ? Normal
11/M 37 2,800 1,5 Pale, RD, HS 9.3 ? Metabolic acidosis 1 Normal
12/M 37 2,800 9,10 Pale 8.5 ? 1 Normal

Abbreviations: Hb, hemoglobin; K-B test, Kleihauer-Betke test; M, male; RD, respiratory distress; HS, hypovolemic shock; RDS, respiratory distress syndrome; F, female; HPLC high performance liquid chromatography; PPHN, persistent pulmonary hypertension of the newborn. ∗Number was matched with maternal cases & newborn cases.

Number of transfusion.

TOOLS
Similar articles